All Stories

  1. Forskolin improves sensitivity to doxorubicin of triple negative breast cancer cells via Protein Kinase A-mediated ERK1/2 inhibition

    Article • Biochemical Pharmacology, June 2018, Elsevier

    Dr Silvio Naviglio

  2. The Influence of the Polymer Amount on the Biological Properties of PCL/ZrO2 Hybrid Materials Synthesized via Sol-Gel Technique

    Article • Materials, October 2017, MDPI AG

    Dr Silvio Naviglio

  3. Adiponectin down-regulates CREB and inhibits proliferation of A549 lung cancer cells

    Article • Pulmonary Pharmacology & Therapeutics, August 2017, Elsevier

    Dr Silvio Naviglio

  4. Chemical analysis and anti-proliferative activity of Campania Thymus Vulgaris essential oil

    Article • Journal of Essential Oil Research, July 2017, Taylor & Francis

    Dr Silvio Naviglio

  5. The Natural cAMP Elevating Compound Forskolin in Cancer Therapy: Is It Time?

    Article • Journal of Cellular Physiology, November 2016, Wiley

    Dr Silvio Naviglio, Prof. Daniele Naviglio

  6. S-Adenosylmethionine Affects ERK1/2 and Stat3 Pathways and Induces Apotosis in Osteosarcoma Cells

    Article • Journal of Cellular Physiology, October 2015, Wiley

    Dr Silvio Naviglio

  7. Inorganic Phosphate Prevents Erk1/2 and Stat3 Activation and Improves Sensitivity to Doxorubicin of MDA-MB-231 Breast Cancer Cells

    Article • Molecules, September 2015, MDPI AG

    Dr Silvio Naviglio

  8. Lactic dehydrogenase and cancer an overview

    Article • Frontiers in Bioscience, January 2015, Frontiers in Bioscience

    Dr Silvio Naviglio

  9. The possible use of inorganic phosphate in osteosarcoma therapy

    Article • Future Oncology, September 2013, Future Medicine

    Dr Silvio Naviglio

  10. Editorial (Hot Topics: Naturally Occurring Molecules and Anticancer Combination Therapies in the Era of Personalized Medicine and Economic Crisis)

    Article • Current Pharmaceutical Design, July 2013, Bentham Science Publishers

    Dr Silvio Naviglio

  11. Inorganic Phosphate as a Signaling Molecule: A Potential Strategy in Osteosarcoma Treatment

    Article • Current Pharmaceutical Design, July 2013, Bentham Science Publishers

    Dr Silvio Naviglio

  12. Synergistic cytotoxic effects of inorganic phosphate and chemotherapeutic drugs on human osteosarcoma cells

    Article • Oncology Reports, February 2013, Spandidos Publications

    Dr Silvio Naviglio

  13. Inorganic Phosphate as a Novel Signaling Molecule with Antiproliferative Action in MDA-MB-231 Breast Cancer Cells

    Article • BioResearch Open Access, February 2013, Mary Ann Liebert Inc

    Dr Silvio Naviglio

  14. Integrating leptin and cAMP signalling pathways in triple-negative breast cancer cells

    Article • Frontiers in Bioscience, January 2013, Frontiers in Bioscience

    Dr Silvio Naviglio

  15. cAMP Elevation Down-Regulatesβ3 Integrin and Focal Adhesion Kinase and Inhibits Leptin-Induced Migration of MDA-MB-231 Breast Cancer Cells

    Article • BioResearch Open Access, December 2012, Mary Ann Liebert Inc

    Dr Silvio Naviglio

  16. Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway

    Article • Journal of Cellular Physiology, October 2012, Wiley

    Dr Silvio Naviglio

  17. 5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress

    Article • Journal of Experimental & Clinical Cancer Research, January 2012, Springer Science + Business Media

    Dr Silvio Naviglio

  18. Targeting p27Kip1protein: its relevance in the therapy of human cancer

    Article • Expert Opinion on Therapeutic Targets, February 2011, Informa Healthcare

    Dr Silvio Naviglio

  19. Novel molecular mechanisms by inorganic phosphate in osteosarcoma U2OS cells

    Article • Frontiers in Bioscience, January 2011, Frontiers in Bioscience

    Dr Silvio Naviglio

  20. Leptin potentiates antiproliferative action of cAMP elevation via protein kinase A down-regulation in breast cancer cells

    Article • Journal of Cellular Physiology, December 2010, Wiley

    Dr Silvio Naviglio

  21. Zoledronic acid: an unending tale for an antiresorptive agent

    Article • Expert Opinion on Pharmacotherapy, December 2009, Informa Healthcare

    Dr Silvio Naviglio

  22. Leptin enhances growth inhibition by cAMP elevating agents through apoptosis of MDA-MB-231 breast cancer cells

    Article • Cancer Biology & Therapy, June 2009, Taylor & Francis

    Dr Silvio Naviglio

  23. Novel molecular mechanisms by inorganic phosphate in osteosarcoma U2OS cells

    Article • Frontiers in Bioscience, January 2009, Frontiers in Bioscience

    Dr Silvio Naviglio

  24. Protein kinase A as a biological target in cancer therapy

    Article • Expert Opinion on Therapeutic Targets, November 2008, Informa Healthcare

    Dr Silvio Naviglio

  25. Change in TNF-αReceptor Expression Is a Relevant Event in Doxorubicin-Induced H9c2 Cardiomyocyte Cell Death

    Article • Journal of Interferon & Cytokine Research, July 2007, Mary Ann Liebert Inc

    Dr Silvio Naviglio

  26. Inorganic phosphate inhibits growth of human osteosarcoma U2OS cells via adenylate cyclase/cAMP pathway

    Article • Journal of Cellular Biochemistry, January 2006, Wiley

    Dr Silvio Naviglio

  27. Adenylate cyclase regulation via proteasome-mediated modulation of Gαs levels

    Article • Cellular Signalling, November 2004, Elsevier

    Dr Silvio Naviglio

  28. Adenylate cyclase regulation via proteasome-mediated modulation of G$alpha;s levels

    Article • Cellular Signalling, May 2004, Elsevier

    Dr Silvio Naviglio

  29. UBPY: a growth-regulated human ubiquitin isopeptidase

    Article • The EMBO Journal, June 1998, Wiley

    Dr Silvio Naviglio